So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...

A woman's hands star in a Lilly spot, shown playing key role in activities like gardening -- and discovering a lump in her ...

Ritu Raju was one of many people who touted Gateway’s diverse offerings Friday during the 2025 State of the College.

Could the drug ads that flash across your television screen ... Three major drug companies — Merck, Eli Lilly and Amgen — sued to block the rule, in part on First Amendment grounds.

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.